Topping the list of new coins is Monsta Mash ($MASH), a GameFi coin blending gaming and the dynamic appeal of the crypto ...

Innovations emerge rapidly in the crypto ecosystem, offering incredible opportunities every day for crypto enthusiasts ...

The crypto space is buzzing as the announcement of 3 coins to consider before 2025 hit the headlines. The Bulls have their ...

Amidst the November bull run frenzy, BTC came a few dollars short of hitting the $100K mark. Two days ago Bitcoin surged to ...

As the crypto market rises to unprecedented heights, various altcoins are capturing the attention of investors seeking ...

As the alt season commences, with ETH leading the rest, an emerging coin, Monsta Mash has caught investors’ attention. The ...

SAN FRANCISCO - 89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company, has announced new findings from the Phase 2b ENLIVEN trial of pegozafermin in patients with metabolic dysfunction ...

Once-monthly efimosfermin demonstrated statistically significant fibrosis improvement ≥1 stage without worsening of MASH vs. placebo after 24-weeks of treatment Two-thirds of efimosfermin ...

Former Londoner Susan Williamson has been serving up traditional pie and mash outside a village pub in Kent for the last 13 years. But with new management due to take over in the new year ...

Analyst Merle Eliana's bullish view comes about a month after the medical journal The Lancet published positive mid-stage trial data for the company's oral MASH candidate denifanstat early this year.

The analyst from UBS highlighted the potential of denifisant as a Phase 3 ready oral medication in a field dominated by injectable treatments for metabolic-associated steatohepatitis (MASH).

The firm highlighted the potential of Inventiva's drug candidate lanifibranor, which is being developed for the treatment of MASH F2/3 and is currently in Phase 3 clinical trials. The analyst ...